Dainippon Sumitomo Pharma opens subsidiary in Singapore

TOKYO —

Dainippon Sumitomo Pharma (DSP) has set up a wholly owned subsidiary, Sunovion Pharmaceuticals Asia Pacific Pte Ltd, in Singapore as a base of operations in Southeast Asia.

DSP said it is progressing its global expansion with its global strategic product, antipsychotic lurasidone hydrochloride (generic name) at the core. As a part of this effort, DSP has considered extending commercial operations for lurasidone hydrochloride to countries in Southeast Asia where growth is expected in the mid-to long term.

DSP said it will first promote business operations such as obtaining approval for and marketing lurasidone hydrochloride in Southeast Asia through partnerships with local companies. Using Singapore as a base of operations, DSP will consider successive expansion of its product lineups in Southeast Asia and additionally business expansion into neighboring countries such as Australia.

JCN Newswire

Login to leave a comment

OR
CareerEngine Top 5 Jobs in Japan for Feb 12

CareerEngine Top 5 Jobs in Japan for Feb 12

Japan Today CareersBusiness Services

80s Hard Rock Night Live

80s Hard Rock Night Live

Hard Rock CafeDining

Executive MBA Open Class

Executive MBA Open Class

Temple University, Japan CampusContinuing Education / MBA

Special Offers

Dubliners Akasaka Anniversary- All pints ¥500!

Dubliners Akasaka Anniversary- All pints ¥500!

Offer ends: Feb 15, 2016Continuing Education / MBA

Work
in
Japan

Search the Largest English Job Board in Japan.

Find a Job Now!

More in Business

View all

View all

Find Your
Apartment
in Japan

10,000’s of properties available today!

Search